J
Joanna H. Sier
Researcher at University of Leeds
Publications - 5
Citations - 108
Joanna H. Sier is an academic researcher from University of Leeds. The author has contributed to research in topics: Medicine & Appetite. The author has an hindex of 2, co-authored 4 publications receiving 76 citations. Previous affiliations of Joanna H. Sier include University of Surrey.
Papers
More filters
Journal ArticleDOI
Efficacy of dietary and physical activity intervention in non-alcoholic fatty liver disease: a systematic review
TL;DR: Results suggest that 5–10% weight loss using a modestly hypocaloric diet of 500 kcal less per day than calculated energy requirement, in combination with 30–60 min exercise on 3–5 days per week should be recommended.
Journal ArticleDOI
Linking physiologically-based pharmacokinetic and genome-scale metabolic networks to understand estradiol biology
TL;DR: It is demonstrated how the novel coupling of PBPK models with genome-scale metabolic networks has the potential to aid prediction of drug action, including both drug-drug interactions and changes to the metabolic landscape that may predispose an individual to disease development.
Journal ArticleDOI
Effects of oral lubrication on satiety, satiation and salivary biomarkers in model foods: A pilot study
Ecaterina Stribițcaia,Catherine Gibbons,Joanna H. Sier,Christine Boesch,John E. Blundell,Graham Finlayson,Anwesha Sarkar +6 more
TL;DR: In this paper, the role of preloads varying in their oral lubricating properties on appetite sensations, food intake, salivary friction and concentration of Salivary biomarkers (proteins, α-amylase and mucins) in collected human saliva (n = 17 healthy participants).
Journal ArticleDOI
Ergothioneine supplementation in people with metabolic syndrome (ErgMS): protocol for a randomised, double-blind, placebo-controlled pilot study.
Xiaoying Tian,Giorgia Cioccoloni,Joanna H. Sier,Khalid M. Naseem,James L. Thorne,J. Bernadette Moore +5 more
TL;DR: The ErgMS study as discussed by the authors was designed as a single-centre, randomised, double-blind, placebo-controlled, 3-arm parallel, pilot intervention trial, which aimed to supplement participants with either placebo, 5 or 30 mg/day ergothioneine for 12 weeks.